NASDAQ: GOCO - GoHealth, Inc.

Yield per half year: +18.71%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis GoHealth, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (11.86%) is higher than the sector average (-9.06%).

Disadvantages

  • Price (12.98 $) is higher than fair price (10.46 $)
  • Dividends (0%) are below the sector average (0.5431%).
  • Current debt level 35.47% has increased over 5 years from 18.23%.
  • The company's current efficiency (ROE=-1.11%) is lower than the sector average (ROE=6.54%)

Similar companies

Alexion

ABIOMED

Amgen

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

GoHealth, Inc. Healthcare Index
7 days 9.6% 1.4% -1.9%
90 days -27.5% -9.9% -17.1%
1 year 11.9% -9.1% 3.6%

GOCO vs Sector: GoHealth, Inc. has outperformed the "Healthcare" sector by 20.92% over the past year.

GOCO vs Market: GoHealth, Inc. has outperformed the market by 8.28% over the past year.

Stable price: GOCO is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: GOCO with weekly volatility of 0.228% over the past year.

3. Summary of the report

3.1. General

P/E: 22.1
P/S: 0.1673

3.2. Revenue

EPS -0.2934
ROE -1.11%
ROA -0.196%
ROIC -18.86%
Ebitda margin 21.74%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (12.98 $) is higher than the fair price (10.46 $).

Price is higher than fair: The current price (12.98 $) is 19.4% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (22.1) is lower than that of the sector as a whole (64.63).

P/E vs Market: The company's P/E (22.1) is lower than that of the market as a whole (93.32).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (0.2915) is lower than that of the sector as a whole (4.52).

P/BV vs Market: The company's P/BV (0.2915) is lower than that of the market as a whole (5.61).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.1673) is lower than that of the sector as a whole (33.51).

P/S vs Market: The company's P/S indicator (0.1673) is lower than that of the market as a whole (10.28).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (3.57) is higher than that of the sector as a whole (-19.11).

EV/Ebitda vs Market: The company's EV/Ebitda (3.57) is lower than that of the market as a whole (19.31).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -19.4% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-19.4%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-26.26%).

5.4. ROE

ROE vs Sector: The company's ROE (-1.11%) is lower than that of the sector as a whole (6.54%).

ROE vs Market: The company's ROE (-1.11%) is lower than that of the market as a whole (5.31%).

5.5. ROA

ROA vs Sector: The company's ROA (-0.196%) is higher than that of the sector as a whole (-0.7601%).

ROA vs Market: The company's ROA (-0.196%) is lower than that of the market as a whole (6.12%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-18.86%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-18.86%) is lower than that of the market as a whole (10.94%).

6. Finance

6.1. Assets and debt

Debt level: (35.47%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 18.23% to 35.47%.

Excess of debt: The debt is not covered by net income, percentage -18031.76%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5431%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
28.11.2022 CCP III Cayman GP Ltd.
10% Owner
Purchase 10.05 387 116 38 519
28.11.2022 CB Blizzard Holdings C, L.P.
10% Owner
Purchase 10.05 387 116 38 519
25.11.2022 CCP III Cayman GP Ltd.
10% Owner
Purchase 9.03 79 563 8 811
25.11.2022 CB Blizzard Holdings C, L.P.
10% Owner
Purchase 9.03 79 563 8 811

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum GoHealth, Inc.

9.3. Comments